Gian Luca Grazi
Gian Luca Grazi
IRCCS Regina Elena National Cancer Institute
Verified email at
Cited by
Cited by
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ...
The lancet oncology 10 (1), 35-43, 2009
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma
L Gramantieri, M Ferracin, F Fornari, A Veronese, S Sabbioni, CG Liu, ...
Cancer research 67 (13), 6092-6099, 2007
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
F Fornari, L Gramantieri, M Ferracin, A Veronese, S Sabbioni, GA Calin, ...
Oncogene 27 (43), 5651-5661, 2008
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells
F Fornari, L Gramantieri, C Giovannini, A Veronese, M Ferracin, ...
Cancer research 69 (14), 5761-5767, 2009
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells
F Fornari, M Milazzo, P Chieco, M Negrini, GA Calin, GL Grazi, D Pollutri, ...
Cancer research 70 (12), 5184-5193, 2010
Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence
G Ercolani, GL Grazi, M Ravaioli, M Del Gaudio, A Gardini, M Cescon, ...
Annals of surgery 237 (4), 536, 2003
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality
L Gramantieri, F Fornari, M Ferracin, A Veronese, S Sabbioni, GA Calin, ...
Clinical cancer research 15 (16), 5073-5081, 2009
Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value
GL Grazi, G Ercolani, F Pierangeli, M Del Gaudio, M Cescon, A Cavallari, ...
Annals of surgery 234 (1), 71, 2001
Liver transplantation for hepatocellular carcinoma: results of down‐staging in patients initially outside the Milan selection criteria
M Ravaioli, GL Grazi, F Piscaglia, F Trevisani, M Cescon, G Ercolani, ...
American Journal of Transplantation 8 (12), 2547-2557, 2008
Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience)
F Trevisani, S De Notariis, G Rapaccini, F Farinati, L Benvegnų, M Zoli, ...
The American journal of gastroenterology 97 (3), 734-744, 2002
Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen–negative patients receiving lamivudine therapy
ASF Lok, M Hussain, C Cursano, M Margotti, A Gramenzi, G Luca Grazi, ...
Hepatology 32 (5), 1145-1153, 2000
Impact of model for end‐stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis
A Cucchetti, G Ercolani, M Vivarelli, M Cescon, M Ravaioli, G La Barba, ...
Liver Transplantation 12 (6), 966-971, 2006
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles
F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ...
Cell reports 18 (11), 2780-2794, 2017
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma
CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ...
Cell reports 23 (1), 313-326. e5, 2018
The system can't perform the operation now. Try again later.
Articles 1–20